CoChat
Sign Up
Cited by 105

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol

Xu, Yu-Xin, Redon, Valeska, Yu, Haojie, Querbes, William, Pirruccello, James, Liebow, Abigail, Deik, Amy, Trindade, Kevin, Wang, Xiao, Musunuru, Kiran, Clish, Clary B., Cowan, Chad, Fizgerald, Kevin, Rader, Daniel, Kathiresan, Sekar·2018·Atherosclerosis
DOI 10.1016/j.atherosclerosis.2017.08.031PMC PMC5750127
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.atherosclerosis.2017.08.031

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Research works printed but not linked: 29

  1. Musunuru, 2010, Genetics of coronary artery disease, Annu. Rev. genomics Hum. Genet., 11, 91, 10.1146/annurev-genom-082509-141637 · DOI
  2. Mattijssen, 2012, Regulation of triglyceride metabolism by Angiopoietin-like proteins, Biochim. Biophys. Acta, 1821, 782, 10.1016/j.bbalip.2011.10.010 · DOI
  3. Romeo, 2009, Rare loss-of-function mutations in ANGPTL family members contribute to plasma triglyceride levels in humans, J. Clin. Invest., 119, 70
  4. Ono, 2003, Protein region important for regulation of lipid metabolism in angiopoietin-like 3 (ANGPTL3): ANGPTL3 is cleaved and activated in vivo, J. Biol. Chem., 278, 41804, 10.1074/jbc.M302861200 · DOI · Paper page
  5. Lee, 2009, Identification of a new functional domain in angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) involved in binding and inhibition of lipoprotein lipase (LPL), J. Biol. Chem., 284, 13735, 10.1074/jbc.M807899200 · DOI · Paper page
  6. Shimamura, 2007, Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase, Arterioscler. Thromb. Vasc. Biol., 27, 366, 10.1161/01.ATV.0000252827.51626.89 · DOI · Paper page
  7. Musunuru, 2010, Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia, N. Engl. J. Med., 363, 2220, 10.1056/NEJMoa1002926 · DOI · Paper page
  8. Miida, 2010, Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events, Curr. Opin. Lipidol., 21, 70, 10.1097/MOL.0b013e328333269e · DOI
  9. Liu, 2010, Angiopoietin-like protein 3 inhibits lipoprotein lipase activity through enhancing its cleavage by proprotein convertases, J. Biol. Chem., 285, 27561, 10.1074/jbc.M110.144279 · DOI · Paper page
  10. Young, 2013, Biochemistry and pathophysiology of intravascular and intracellular lipolysis, Genes Dev., 27, 459, 10.1101/gad.209296.112 · DOI
  11. Choi, 2002, Endothelial lipase: a new lipase on the block, J. Lipid Res., 43, 1763, 10.1194/jlr.R200011-JLR200 · DOI
  12. Ishida, 2003, Endothelial lipase is a major determinant of HDL level, J. Clin. Invest., 111, 347, 10.1172/JCI16306 · DOI
  13. Robciuc, 2010, Quantitation of serum angiopoietin-like proteins 3 and 4 in a Finnish population sample, J. Lipid Res., 51, 824, 10.1194/jlr.M002618 · DOI
  14. Gusarova, 2015, ANGPTL3 blockade with a human monoclonal antibody reduces plasma lipids in dyslipidemic mice and monkeys, J. Lipid Res., 56, 1308, 10.1194/jlr.M054890 · DOI · Paper page
  15. Powell-Braxton, 1998, A mouse model of human familial hypercholesterolemia: markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat chow diet, Nat. Med., 4, 934, 10.1038/nm0898-934 · DOI · Paper page
  16. Millar, 2002, Normal production rate of apolipoprotein B in LDL receptor-deficient mice, Arterioscler. Thromb. Vasc. Biol., 22, 989, 10.1161/01.ATV.0000018304.30943.06 · DOI
  17. Akinc, 2008, A combinatorial library of lipid-like materials for delivery of RNAi therapeutics, Nat. Biotechnol., 26, 561, 10.1038/nbt1402 · DOI · Paper page
  18. Xu, 2010, Inhibition of Golgi apparatus glycosylation causes endoplasmic reticulum stress and decreased protein synthesis, J. Biol. Chem., 285, 24600, 10.1074/jbc.M110.134544 · DOI
  19. Bilheimer, 1972, The metabolism of very low density lipoprotein proteins. I. Preliminary in vitro and in vivo observations, Biochim. Biophys. Acta, 260, 212, 10.1016/0005-2760(72)90034-3 · DOI
  20. Sanjana, 2014, Improved vectors and genome-wide libraries for CRISPR screening, Nat. Methods, 11, 783, 10.1038/nmeth.3047 · DOI · Paper page
  21. Cho, 2014, Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases, Genome Res., 24, 132, 10.1101/gr.162339.113 · DOI · Paper page
  22. Stephan, 1993, Rapid fluorometric assay of LDL receptor activity by DiI-labeled LDL, J. Lipid Res., 34, 325, 10.1016/S0022-2275(20)40759-X · DOI
  23. Mascanfroni, 2015, Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-alpha, Nat. Med., 21, 638, 10.1038/nm.3868 · DOI
  24. Koishi, 2002, Angptl3 regulates lipid metabolism in mice, Nat. Genet., 30, 151, 10.1038/ng814 · DOI · Paper page
  25. Grass, 1995, Transgenic mice expressing both human apolipoprotein B and human CETP have a lipoprotein cholesterol distribution similar to that of normolipidemic humans, J. lipid Res., 36, 1082, 10.1016/S0022-2275(20)39866-7 · DOI
  26. Emerging Risk Factors, 2009, Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993, 10.1001/jama.2009.1619 · DOI · Paper page
  27. Schaefer, 2013, Effects of cholesteryl ester transfer protein inhibitors on human lipoprotein metabolism: why have they failed in lowering coronary heart disease risk?, Curr. Opin. Lipidol., 24, 259, 10.1097/MOL.0b013e3283612454 · DOI
  28. Tall, 1993, Plasma cholesteryl ester transfer protein, J. lipid Res., 34, 1255, 10.1016/S0022-2275(20)36957-1 · DOI · Paper page
  29. Agellon, 1991, Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice, J. Biol. Chem., 266, 10796, 10.1016/S0021-9258(18)99088-5 · DOI

Cited by

Sorted by citations

Metadata

Authors
Xu, Y.-X., Redon, V., Yu, H., Querbes, W., Pirruccello, J., Liebow, A., Deik, A., Trindade, K., Wang, X., Musunuru, K., Clish, C. B., Cowan, C., Fizgerald, K., Rader, D., & Kathiresan, S.
Venue
Atherosclerosis
Publisher
Elsevier BV
Published
2018-01
Volume
268
Pages
196-206
ISSN
0021-9150
DOI
10.1016/j.atherosclerosis.2017.08.031
PMC
PMC5750127
Cited by
105
References
6
Language
en
Licence
Funders
  • National Heart, Lung, and Blood Institute (R37-HL055323, RC2-HL101864, R33-HL120781)
  • Massachusetts General Hospital (MGH)
  • MGH
  • Donovan Family Foundation
  • Foundation Leducq (12-CDA-04)
  • American Heart Association SDG (11SDG7670007)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review